SCHEMBL7496987

SCHEMBL7496987

CN(Cc1nc(-c2ccccc2)c(-c2ccccc2)o1)C1CCc2c(OCC(=O)O)cccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 11/20 0.49
PTGIR P43119 2/20 0.47
PPARD Q03181 3/20 0.44
NR4A1 P22736 3/20 0.43
NR4A3 Q92570 3/20 0.43
RXRA P19793 5/20 0.41
RXRB P28702 4/20 0.41
RXRG P48443 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ABCC4 O15439 1/20 0.41
C5 P01031 1/20 0.41
LMNA P02545 1/20 0.41
CHRM2 P08172 1/20 0.41
CYP3A4 P08684 1/20 0.41
CHRM1 P11229 1/20 0.41
DRD2 P14416 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
TBXA2R P21731 1/20 0.41
PTGS1 P23219 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7489527 0.95 PTGIR (0.51) NR4A2PTGIRPPARDNR4A1NR4A3
SCHEMBL7492835 0.91 PTGIR (0.44) NR4A2PTGIRPPARDNR4A1NR4A3
SCHEMBL7497865 0.90 PTGIR (0.46) NR4A2PTGIRPPARDNR4A1NR4A3
SCHEMBL7495137 0.90 PTGIR (0.46) NR4A2PTGIRPPARDNR4A1NR4A3
SCHEMBL7498928 0.89 PTGIR (0.45) NR4A2PTGIRPPARDNR4A1NR4A3
SCHEMBL7488291 0.88 PTGIR (0.46) NR4A2PTGIRPPARDNR4A1NR4A3
SCHEMBL7485192 0.88 PTGIR (0.48) NR4A2PTGIRPPARDKDM4ECYP3A4
SCHEMBL7497308 0.88 PTGIR (0.49) NR4A2PTGIRPPARDNR4A1NR4A3
SCHEMBL7484361 0.87 NR4A2 (0.44) NR4A2PTGIRNR4A1NR4A3RXRA
SCHEMBL8589864 0.85 PTGIR (0.45) NR4A2PTGIRPPARDNR4A1NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
EP-0842161-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-20 EP disclosed
WO-1997003973-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed